Cytovance Biologics Launches In-House Cell Line Development with High-Yield Titers up to 10g/L

Cytovance Biologics®, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its mammalian cell culture ...
GEN

Framework to Optimize Mammalian Cell Culture Media Blending

In biopharmaceutical manufacturing, optimizing chemically defined media (CDM) is critical for enhancing cell growth, productivity, and product quality in mammalian cell cultures. Traditional screening ...
Yahoo Finance

Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®

REDDING, Calif., June 30, 2025 /PRNewswire/ --According to a comprehensive market research report titled "Europe Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration ...
The Scientist

Protein Evolution in Mammalian Cells May Improve Therapeutics

Thought too hard to do, a new platform evolved proteins in mammalian cells, which could help researchers design drugs that work better in humans. “There are many, many examples, both published and ...